- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| SHENZHEN EDGE MEDICAL Aktie jetzt für 0€ handeln | |||||
| Mo | EDGE MEDICAL-B (02675): NEXT DAY DISCLOSURE RETURN | 2 | HKEx | ||
| 28.08. | EDGE MEDICAL-B (02675): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026 | 5 | HKEx | ||
| 18.08. | EDGE MEDICAL-B (02675): DATE OF BOARD MEETING | 1 | HKEx | ||
| 29.07. | EDGE MEDICAL-B (02675): COMPLETION OF CHANGE OF REGISTERED ADDRESS | 3 | HKEx | ||
| 24.07. | EDGE MEDICAL-B (02675): VOLUNTARY ANNOUNCEMENT INVESTMENT IN PRIMALVERSE | 2 | HKEx | ||
| 22.07. | EDGE MEDICAL-B (02675): NEXT DAY DISCLOSURE RETURN | 3 | HKEx | ||
| 06.07. | XFRA NEW INSTRUMENTS AVAILABLE ON 06.07.2026 | 779 | Xetra Newsboard | The following instruments on XETRA do have their first trading 06.07.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 06.07.2026
Aktien
1 US26853E1029 EHang Holdings Ltd.
2... ► Artikel lesen | |
| 02.07. | EDGE MEDICAL-B (02675): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| 25.06. | EDGE MEDICAL-B (02675): ARTICLES OF ASSOCIATION | 4 | HKEx | ||
| 25.06. | EDGE MEDICAL-B (02675): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 25, 2026 | 1 | HKEx | ||
| 22.06. | EDGE MEDICAL-B (02675): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
| 12.06. | EDGE MEDICAL-B (02675): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| 09.06. | EDGE MEDICAL-B (02675): VOLUNTARY ANNOUNCEMENT INTENTION TO CONDUCT ON-MARKET SHARE REPURCHASE | 1 | HKEx | ||
| 03.06. | EDGE MEDICAL-B (02675): PROXY FORM FOR THE ANNUAL GENERAL MEETING TO BE HELD ON JUNE 25, 2026 | 1 | HKEx | ||
| 03.06. | EDGE MEDICAL-B (02675): NOTICE OF THE ANNUAL GENERAL MEETING | - | HKEx | ||
| 03.06. | EDGE MEDICAL-B (02675): CIRCULAR FOR ANNUAL GENERAL MEETING | - | HKEx | ||
| 01.06. | EDGE MEDICAL-B (02675): PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION | - | HKEx | ||
| 28.04. | EDGE MEDICAL-B (02675): EDGE MEDICAL ESG REPORT 2025 | - | HKEx | ||
| 28.04. | EDGE MEDICAL-B (02675): 2025 ANNUAL REPORT | - | HKEx | ||
| 27.03. | EDGE MEDICAL-B (02675): ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025 | - | HKEx |
1 2 Weiter >>
23 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 43,630 | -1,35 % | AKTIEN IM FOKUS: Zinsanstieg birgt Gefahren für sichere Aktienhäfen | FRANKFURT (dpa-AFX) - Steigende Zinsen an den Kapitalmärkten haben zum Wochenbeginn die Aktienkurse von als sichere Anlagen geltenden Unternehmen belastet. Dazu zählen unter anderen die Immobilienwerte... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,220 | +1,61 % | Fresenius Medical Care: Stabilität in stürmischen Zeiten dank robustem Geschäftsmodell | ||
| SIEMENS HEALTHINEERS | 39,000 | +0,49 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| BILLIONTOONE | 99,50 | 0,00 % | Canaccord initiates BillionToOne stock coverage with buy rating | ||
| CARL ZEISS MEDITEC | 31,560 | -1,87 % | Vom Patent zum Umsatz: Wie Health-Tech-Innovationen den Milliardenmarkt Augengesundheit erreichen - und warum für Rise Nano Optics jetzt die entscheidende Phase beginnt | ||
| HEARTFLOW | 48,880 | 0,00 % | Heartflow, Inc.: Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half | FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 13,530 | 0,00 % | Alignment Healthcare Reports Second Quarter 2026 Results, Surpassing High End of Guidance Across All Key Metrics | Generates $1.3 billion in total revenue, representing 31.6% growth year-over-year Grows Medicare Advantage membership 31.5% year-over-year to approximately 294,100 membersRaises the midpoint of all... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 60,75 | +0,03 % | Can BTSG Outgrow the $20B Acute Infusion Market on Volume Growth? | ||
| SANARA MEDTECH | 34,740 | +0,03 % | Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited) | FORT WORTH, TX, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. ("Sanara," "Sanara MedTech," the "Company," "we," "our" or "us") (Nasdaq: SMTI), a medical technology company focused on developing... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 22,790 | +0,13 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BETA BIONICS | 19,410 | -0,05 % | Beta Bionics, Inc.: Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance | IRVINE, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 13,580 | 0,00 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 12,730 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| PROGYNY | 25,930 | 0,00 % | Progyny stock price target maintained at $31 by Citizens on new offering | ||
| GENEDX | 85,98 | 0,00 % | GeneDx study shows rapid genome sequencing benefits beyond ICUs |
Das Unternehmen SHENZHEN EDGE MEDICAL CO LTD kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 3,500 Euro und damit +4,48 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SHENZHEN EDGE MEDICAL CO LTD finden Sie auf Wallstreet Online.